Alterity Therapeutics announces annual general meeting details
Alterity Therapeutics Ltd shares details of its annual general meeting and proxy form, emphasizing transparency in the pharmaceutical preparations industry.
BCE announces preferred share conversions effective Nov. 2
BCE Inc. reports on Series S and T preferred share conversions, impacting its capital structure and reflecting industry trends in telecommunications.
Ballard Power Systems announces Q3 2026 results call
Ballard Power Systems will hold a conference call on November 16, 2026, to discuss Q3 2026 results, emphasizing transparency and stakeholder engagement.
Nanobiotix Reports Voting Rights and Shares Capital Update
Nanobiotix S.A. updates its voting rights and shares capital as of September 30, 2026, highlighting transparency in governance and shareholder engagement.
Foresight Autonomous updates corporate presentation
Foresight Autonomous Holdings Ltd. has released an updated corporate presentation, enhancing transparency and engagement with stakeholders.
Golden Sun Technology Group files for Annual General Meeting
Golden Sun Technology Group Ltd. files important documents for its Annual General Meeting, emphasizing transparency and governance in the educational services sector.
Golden Sun Technology Group appoints new director amid changes
Golden Sun Technology Group Ltd. appoints Bekazela Matshazi as a director after Liming Xu's resignation, signaling a strategic shift in leadership.
Pharming Group reports strong Q3 2026 results, raises outlook
Pharming Group N.V. announces Q3 2026 revenues of $117.6 million, exceeding expectations and tightening its revenue guidance for the year.
Linkage Global Regains Nasdaq Compliance with Bid Price
Linkage Global Inc announces it has regained compliance with Nasdaq's minimum bid price requirement, marking a positive turnaround for the company.
Alvotech Receives FDA Approval for New SIMLANDI® Process
Alvotech secures FDA approval for a new manufacturing process for SIMLANDI®, enhancing production capacity and efficiency in the biosimilar market.
Ituran Location schedules third quarter 2026 results release
Ituran Location & Control Ltd. announces its third quarter 2026 results and conference call scheduled for November 24, 2026.
Axonex AI Group Announces Reverse Stock Split to Comply with Nasdaq
Axonex AI Group Ltd announces a reverse stock split to meet Nasdaq listing requirements, reducing outstanding shares significantly.
Turkcell sets date for Q3 2026 financial results
Turkcell İletişim Hizmetleri A.Ş. announces the date for its Q3 2026 financial results, signaling commitment to transparency in the telecommunications sector.
Innate Pharma sets date for Q3 2026 business update call
Innate Pharma SA will hold a conference call on November 5, 2026, to discuss its Q3 2026 business and financial update.
HUTCHMED finalizes licensing deal with GSK for cancer therapy
HUTCHMED (China) Ltd announces the closing of a licensing agreement with GSK for its KRAS-EGFR-antibody conjugate therapy, enhancing its oncology portfolio.
Newegg Commerce closes $100 million senior credit facility
Newegg Commerce, Inc. announces the closing of a $100 million senior credit facility to enhance financial flexibility and support growth initiatives.
B.O.S. Better Online Solutions schedules annual shareholder meeting
B.O.S. Better Online Solutions Ltd. announces its annual shareholder meeting on December 10, 2026, addressing key governance and compensation issues.
ChowChow Cloud reports unusual trading activity on NYSE
ChowChow Cloud International Holdings Ltd reports unusual trading activity in its shares on the NYSE American, raising questions about market stability.
Tungray Technologies faces legal ruling from ICBC
Tungray Technologies Inc is appealing a court ruling that favors ICBC in a loan dispute, which may impact the company's financial standing and operations.
Onconetix Announces One-for-Ten Reverse Stock Split
Onconetix, Inc. announces a one-for-ten reverse stock split effective November 6, 2026, aiming to consolidate shares and improve market perception.